| Structure | Chemical Name | CAS | MF |
|
n‐(3‐bromo‐1‐methyl‐1h‐indazol‐5‐yl)acetamide
|
1788044-08-5
|
C10H10BrN3O
|
|
3-[1-(4-aminobutyl)-1h-1,2,3-triazol-4-yl]aniline trihydrochloride
|
1788044-10-9
|
C12H18ClN5
|
|
methyl 6-hydrazinylpyridazine-3-carboxylate dihydrochloride
|
1788044-11-0
|
C6H9ClN4O2
|
|
tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride
|
1788044-12-1
|
C11H21ClN2O2
|
|
(5-methylpyridazin-3-yl)methanol
|
1788044-13-2
|
C6H8N2O
|
|
tert-Butyl (2-(azetidin-3-yl)propan-2-yl)carbamate hydrochloride
|
1788044-14-3
|
C11H23ClN2O2
|
|
methyl 5-methylpyridazine-3-carboxylate
|
1788044-15-4
|
C7H8N2O2
|
|
3-Bromo-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrobromide
|
1788044-16-5
|
C7H9Br2NS
|
|
4‐chloro‐2‐iodo‐7‐methyl‐7h‐pyrrolo[2,3‐b]pyridine
|
1788054-66-9
|
C8H6ClIN2
|
|
sodium 1-benzyl-4-(methoxycarbonyl)-2,5-dihydro-1h-pyrrol-3-olate
|
1788054-67-0
|
C13H16NNaO3
|
|
tert-Butyl 2,7-diazaspiro[4.4]nonane-2-carboxylate oxalate(2:1)
|
1788054-69-2
|
C14H24N2O6
|
|
1H-imidazole-2-carboximidamide dihydrochloride
|
1788054-71-6
|
C4H7ClN4
|
|
tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate oxalate(2:1)
|
1788054-74-9
|
C13H22N2O6
|
|
(1R,2R,4S)-rel-7-Azabicyclo[2.2.1]heptan-2-ol
|
1788054-75-0
|
C6H12ClNO
|
|
1-(5-Bromo-3-iodo-6-methyl-1H-indazol-1-yl)ethanone
|
1788054-76-1
|
C10H8BrIN2O
|
|
5'‐bromo‐1'‐ethenyl‐1',2'‐ dihydrospiro[cyclopropane‐1,3'‐indole]‐2'‐one
|
1788054-77-2
|
C12H10BrNO
|
|
(2R,3R)-rel-3-(2,2,2-Trifluoroacetoxy)pyrrolidine-2-carboxylic acid
|
1788054-78-3
|
C7H10F3NO5
|
|
6,6-difluoro-3-azabicyclo[3.1.1]heptane hydrochloride
|
1788054-81-8
|
C6H10ClF2N
|
|
(5-Methylpyridazin-3-yl)methanamine hydrochloride
|
1788054-82-9
|
C6H10ClN3
|
|
3-(Trifluoromethyl)cyclobutanol
|
1788054-83-0
|
C5H7F3O
|
|
tert-butyl 4-(1-hydroxycyclopropanecarbonyl)piperazine-1-carboxylate
|
1788054-84-1
|
C13H22N2O4
|
|
3-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-amine
|
1788054-90-9
|
C12H14BrN3O
|
|
tert-Butyl 5-amino-2-azaspiro[3.3]heptane-2-carboxylate hydrochloride
|
1788054-91-0
|
C11H21ClN2O2
|
|
tert-Butyl 6-amino-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate
|
1788054-94-3
|
C14H18N2O3
|
|
(S)-Methyl 3-(2-chloropyridin-4-yl)-3-cyclopropylpropanoate
|
1788058-39-8
|
C12H14ClNO2
|
|
tert-butyl N-methyl-N-[(3S)-pyrrolidin-3-yl]carbamate hydrochloride
|
1788058-40-1
|
C10H21ClN2O2
|
|
(R)-4-Aminopyrrolidin-2-one hydrochloride
|
1788058-41-2
|
C4H9ClN2O
|
|
di-tert-butyl(3-(tert-butyl)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)phosphine oxide
|
1788085-46-0
|
C20H34O3P2
|
|
di-tert-butyl((2R,3R)-3-(tert-butyl)-4-(dimethylamino)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)phosphine oxide
|
1788085-47-1
|
C21H37NO2P2
|
|
Vitexolide D
|
1788090-69-6
|
C20H30O3
|
|
(9H-Fluoren-9-yl)MethOxy]Carbonyl MeDbz-OH
|
1788861-35-7
|
C23H20N2O4
|
|
Iopamidol Impurity K
|
1788899-70-6
|
C17H23I2N3O8
|
|
Lenvatinib Impurity 5
|
1788901-86-9
|
C21H19ClN4O5
|
|
Amoxicillin EP Impurity L
|
1789703-32-7
|
C24H29N5O7S2
|
|
Vildagliptin Related Compound F
|
1789703-36-1
|
C17H24N2O3
|
|
vildagliptin Impurity E
|
1789703-37-2
|
C17H25N3O2
|
|
(1-Benzyl-2,5-dioxoimidazolidin-4-yl)acetic acid
|
1790213-67-0
|
C12H12N2O4
|
|
CeMMEC13
|
1790895-25-8
|
C19H16N2O4
|
|
tert-butyl N-[(2R,3R)-2-methylpiperidin-3-yl]carbamate
|
1791402-58-8
|
C11H22N2O2
|
|
4-(1-(trifluoromethyl)cyclopropyl)aniline
|
1791402-68-0
|
C10H10F3N
|
|
10-(4-(4-(9H -carbazol-9-yl)phenylsulfonyl)phenyl)-9,9-dimethyl- 9,10-dihydroacridine
|
1792173-34-2
|
C39H30N2O2S
|
|
1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
|
1792180-81-4
|
C15H19N5O
|
|
N-((3R,6S)-6-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
1792184-37-2
|
C12H17N5
|
|
3-Chloro-2-iodo-4- (trifluoromethoxy)aniline
|
1792885-92-7
|
C7H4ClF3INO
|
|
NCB-0846
|
1792999-26-8
|
C21H21N5O2
|
|
11-Deoxymogroside IIIE
|
1793003-47-0
|
C48H82O18
|
|
(R)-Gyramide A Hydrochloride
|
1793050-70-0
|
C21H28ClFN2O3S
|
|
LLY-507
|
1793053-37-8
|
C36H42N6O
|
|
PIRIMIPHOS-METHYL D6
|
1793055-06-7
|
C11H20N3O3PS
|
|
2-Desbutylcarboxy-2-(N-hydroxyheptanamino) Bendamustine
|
1793059-58-1
|
C19H29Cl3N4O2
|
|
[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid
|
1793086-11-9
|
C13H11NO3S2
|
|
(E)-2-(5-(2-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
|
1793086-16-4
|
C12H8ClNO3S2
|
|
[2-AMINO-5-(TRIFLUOROMETHYL)PHENYL]BORONIC ACID
|
1793091-29-8
|
C7H7BF3NO2
|
|
Pyrano[2,3-c]pyrazole-5-carbonitrile,6-amino-1-(4-chlorophenyl)-1,4-dihydro-3-methyl-4-phenyl-, (4S)-
|
1793093-50-1
|
C20H15ClN4O
|
|
(9H-Fluoren-9-yl)MethOxy]Carbonyl N-Me-D-Lys(Boc)-OH
|
1793105-27-7
|
C27H34N2O6
|
|
(9H-Fluoren-9-yl)MethOxy]Carbonyl N-Me-Orn(Boc)-OH
|
1793105-28-8
|
C26H32N2O6
|
|
2-AMino-3-chloro-propionohydroxaMic-15N,d3 Acid
|
1794713-69-1
|
C3H7ClN2O2
|
|
(5-chloropyrazin-2-yl)methanamine hydrochloride
|
1794737-26-0
|
C5H7Cl2N3
|
|
4-AMino-N-[(1-(ethyl-d5)-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)-2-
MethoxybenzaMide N-Oxide
|
1794756-15-2
|
C17H22D5N3O5S
|
|
Roflumilast N-oxide D4
|
1794760-31-8
|
C17H14Cl2F2N2O4
|
|
6-[2-(3,4-Dihydro-4,4-(diMethyl-d6)-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic Acid
|
1794760-38-5
|
C19H17NO2S
|
|
LAS-31416-d6 Hydrochloride
|
1794782-57-2
|
C17H25ClN3O2S
|
|
Vilazodone-d8
|
1794789-93-7
|
C26H26N5O2
|
|
3-AMino-6-broMo-4-(2-chlorophenyl)-2(1H)-quinolinone-d5
|
1794793-32-0
|
C15H5BrClD5N2O
|
|
2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]Methyl]benziMidazole-7-carboxylic Acid-d4
|
1794817-45-0
|
C25H16D4N4O5
|
|
NSC 69
|
1794941-44-8
|
C14H11ClN2O4S
|
|
DICHLOROACETALDEHYDE HYDRATE
|
1795013-22-7
|
C2H4Cl2O2
|
|
Formoterol EP Impurity F
|
1795129-59-7
|
C37H46N4O6
|
|
Formoterol EP Impurity D
|
1795133-96-8
|
C20H26N2O4
|
|
Formoterol EP Impurity C
|
1795135-61-3
|
C20H26N2O4
|
|
ALDICARB D3
|
1795142-83-4
|
C7H11D3N2O2S
|
|
5-(AcetyliMino)-4,5-dihydro-4-Methyl-1,3,4-thiadiazole-2-sulfonic Acid-d3
|
1795143-17-7
|
C5H4D3N3O4S2
|
|
2-Bromo-1-(3-fluoro-pyridin-2-yl)-ethanone hydrobromide
|
1795174-00-3
|
C7H6Br2FNO
|
|
2-BroMo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid Methyl ester
|
1795232-59-5
|
C8H6BrN3O2
|
|
3-(Phenylhexyl)phenylboronic acid
|
1795440-43-5
|
C18H23BO2
|
|
N-(2,6-dimethylphenyl)nicotinamide
|
1795692-55-5
|
C14H14N2O.ClH
|
|
(R)-Tamsulosin-d3 Hydrochloride
|
1795787-12-0
|
C20H29ClN2O5S
|
|
JLEQLXGZAIAEFX-VRQJEYPFSA-N
|
1795790-92-9
|
C22H19N3O5
|
|
8-Hydroxy Entecavir
|
1795791-10-4
|
C12H15N5O4
|
|
Tenofovir Monomethyl Ester
|
1796539-83-7
|
C10H16N5O4P
|
|
Tenofovirdisoproxil Impurity
|
1796539-92-8
|
C16H26N5O7P
|
|
Tenofovir impurity E
|
1796545-19-1
|
C11H18N5O4P
|
|
Orexin 2 Receptor Agonist
|
1796565-52-0
|
C32H34N4O5S
|
|
NSC23005 Sodium
|
1796596-46-7
|
C13H18NNaO4S
|
|
Parimifasor
|
1796641-10-5
|
C18H11Cl2F4N5O
|
|
Aripiprazole USP RC H
|
1796928-63-6
|
C27H35Cl2N3O3
|
|
Dutasteride Impurity E (Dutasteride 17-alfa-epimer)
|
1796930-46-5
|
C27H30F6N2O2
|
|
Mirabegron Impurity
|
1796931-48-0
|
C21H24N4O2S
|
|
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine Formamide Hydrochloride
|
1796934-51-4
|
C15H22ClN5O3
|
|
N-(4-{[(1-Tetrahydro-2H-pyran-4-yl-1H-pyrazol-4-yl)amino]sulfonyl}phenyl)acetamide
|
1796948-68-9
|
C16H20N4O4S
|
|
5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid 1-Methylethyl Ester
|
1797008-41-3
|
C19H28ClN3O3
|
|
Bisoprolol EP Impurity J
|
1797024-50-0
|
C15H24O5
|
|
(4-tert-Butyl-1-pyrrol-1-yl-cyclohexyl)-acetic acid
|
1797082-24-6
|
C16H25NO2
|
|
Busulfan IMpurity 1
|
1797106-48-9
|
C6H14O5S2
|
|
C-Desmethyl Atenolol
|
1797116-92-7
|
C13H20N2O3
|
|
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-propyl ester
|
1797124-83-4
|
C38H45N3O6
|
|
Acyclovir N-Methylene Dimer
|
1797131-64-6
|
C17H22N10O6
|
|
Guaifenesin EP Impurity C
|
1797132-23-0
|
C20H26O7
|
|
Bisoprolol EP Impurity C
|
1797132-90-1
|
C23H34N2O4
|
|
Avibactam Impurity
|
1797133-98-2
|
C7H12N3NaO6S
|